220 related articles for article (PubMed ID: 15254233)
1. Genetic evidence for functional dependency of p18Ink4c on Cdk4.
Pei XH; Bai F; Tsutsui T; Kiyokawa H; Xiong Y
Mol Cell Biol; 2004 Aug; 24(15):6653-64. PubMed ID: 15254233
[TBL] [Abstract][Full Text] [Related]
2. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.
Bai F; Pei XH; Nishikawa T; Smith MD; Xiong Y
Mol Cell Biol; 2007 Feb; 27(4):1495-504. PubMed ID: 17145768
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
5. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
Noh SJ; Li Y; Xiong Y; Guan KL
Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
[TBL] [Abstract][Full Text] [Related]
6. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.
Kovalev GI; Franklin DS; Coffield VM; Xiong Y; Su L
J Immunol; 2001 Sep; 167(6):3285-92. PubMed ID: 11544316
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
[TBL] [Abstract][Full Text] [Related]
8. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
9. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
10. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.
Morishita A; Masaki T; Yoshiji H; Nakai S; Ogi T; Miyauchi Y; Yoshida S; Funaki T; Uchida N; Kita Y; Funakoshi F; Usuki H; Okada S; Izuishi K; Watanabe S; Kurokohchi K; Kuriyama S
Hepatology; 2004 Sep; 40(3):677-86. PubMed ID: 15349907
[TBL] [Abstract][Full Text] [Related]
13. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
Franklin DS; Godfrey VL; Lee H; Kovalev GI; Schoonhoven R; Chen-Kiang S; Su L; Xiong Y
Genes Dev; 1998 Sep; 12(18):2899-911. PubMed ID: 9744866
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
Damo LA; Snyder PW; Franklin DS
Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
[TBL] [Abstract][Full Text] [Related]
15. Pituitary hyperplasia in glycoprotein hormone alpha subunit-, p18(INK4C)-, and p27(kip-1)-null mice: analysis of proteins influencing p27(kip-1) ubiquitin degradation.
Lloyd RV; Ruebel KH; Zhang S; Jin L
Am J Pathol; 2002 Mar; 160(3):1171-9. PubMed ID: 11891212
[TBL] [Abstract][Full Text] [Related]
16. The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate.
Stein J; Milewski WM; Dey A
Islets; 2013; 5(4):156-69. PubMed ID: 23896637
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1.
Huang X; Di Liberto M; Cunningham AF; Kang L; Cheng S; Ely S; Liou HC; Maclennan IC; Chen-Kiang S
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17789-94. PubMed ID: 15591344
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
Tsutsui T; Hesabi B; Moons DS; Pandolfi PP; Hansel KS; Koff A; Kiyokawa H
Mol Cell Biol; 1999 Oct; 19(10):7011-9. PubMed ID: 10490638
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
Jeffrey PD; Tong L; Pavletich NP
Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
[TBL] [Abstract][Full Text] [Related]
20. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.
Pei XH; Bai F; Smith MD; Xiong Y
Cancer Res; 2007 Apr; 67(7):3162-70. PubMed ID: 17409423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
